.jpg)
.jpg)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, St...
Human medicines European public assessment report (EPAR): Xoanacyl, ferric citra...
Human medicines European public assessment report (EPAR): Insulin Human Rechon, ...
Human medicines European public assessment report (EPAR): Cinainu, dry aqueous e...
Orphan designation: Givinostat Treatment of Duchenne muscular dystrophy, 04/07/2...
Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products ...
HMPC: overview of assessment work - priority list
BioAtla is laying off 30% of staff as the biotech searches for partners for some...
Clinical Trials Information System (CTIS): Information day, Online, European Med...
Policy 85: Identity and Access Management to EMA IT Systems
"The letter canceling my public health project ended with ‘Respectfully,’ of all...
The decision to end research on vaccine hesitancy is deeply disrespectful of tho...
At meeting on human embryo editing, CRISPR pioneer says science is a long way fr...
Food programs, outbreak monitoring, mental health aid: state and local health of...
A study published in Lancet HIV Thursday showed that patients who received gende...
Deputy directors at the FDA center that oversees the regulation of cancer drugs ...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
The FDA has cleared a system designed to clean out the complex inner channels of...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
A team of scientists at the National Institutes of Health has developed an eye d...
Cardio-focused company Kardigan is sewing a new digital data platform into its R...
As it faces uncertainty in the research market at home and abroad, Illumina is m...